SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

被引：0

作者：

Constanze Schneider

Thomas Oellerich

Hanna-Mari Baldauf

Sarah-Marie Schwarz

Dominique Thomas

Robert Flick

Hanibal Bohnenberger

Lars Kaderali

Lena Stegmann

Anjali Cremer

Margarethe Martin

Julian Lohmeyer

Martin Michaelis

Veit Hornung

Christoph Schliemann

Wolfgang E Berdel

Wolfgang Hartmann

Eva Wardelmann

Federico Comoglio

Martin-Leo Hansmann

Alexander F Yakunin

Gerd Geisslinger

Philipp Ströbel

Nerea Ferreirós

Hubert Serve

Oliver T Keppler

Jindrich Cinatl

机构：

[1] Institute of Medical Virology,Department of Medicine II

[2] University of Frankfurt,Cambridge University Department of Haematology

[3] Hematology and Oncology,Department of Virology

[4] ,Department of Chemical Engineering and Applied Chemistry

[5] Goethe University of Frankfurt,Gene Center and Department of Biochemistry

[6] Cambridge Institute of Medical Research,Department of Medicine A (Hematology

[7] German Cancer Consortium partner site,undefined

[8] German Cancer Research Center,undefined

[9] Max von Pettenkofer Institute,undefined

[10] Ludwig Maximilian University of Munich,undefined

[11] Pharmazentrum frankfurt/ZAFES,undefined

[12] ,undefined

[13] Institute of Clinical Pharmacology,undefined

[14] Goethe University of Frankfurt,undefined

[15] University of Toronto,undefined

[16] Institute of Pathology,undefined

[17] University Medical Center,undefined

[18] Institute of Bioinformatics,undefined

[19] University Medicine Greifswald,undefined

[20] Centre for Molecular Processing and School of Biosciences,undefined

[21] University of Kent,undefined

[22] Institute of Molecular Medicine,undefined

[23] University Hospital Bonn,undefined

[24] Ludwig Maximilian University of Munich,undefined

[25] Oncology),undefined

[26] University Hospital Münster,undefined

[27] Gerhard Domagk Institute for Pathology,undefined

[28] University Hospital Münster,undefined

[29] Senckenberg Institute of Pathology,undefined

[30] University of Frankfurt,undefined

[31] Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),undefined

[32] Project Group Translational Medicine and Pharmacology (TMP),undefined

来源：

Nature Medicine | 2017年 / 23卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The therapeutic response of acute myeloid leukemia to the nucleoside analog Ara-C is controlled by SAMHD1, an enzyme that hydrolyzes the active metabolite Ara-CTP.

引用

页码：250 / 255

页数：5

共 50 条

[21] Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
Nikolas Herold
Sean G Rudd
Linda Ljungblad
Kumar Sanjiv
Ida Hed Myrberg
Cynthia B J Paulin
Yaser Heshmati
Anna Hagenkort
Juliane Kutzner
Brent D G Page
José M Calderón-Montaño
Olga Loseva
Ann-Sofie Jemth
Lorenzo Bulli
Hanna Axelsson
Bianca Tesi
Nicholas C K Valerie
Andreas Höglund
Julia Bladh
Elisée Wiita
Mikael Sundin
Michael Uhlin
Georgios Rassidakis
Mats Heyman
Katja Pokrovskaja Tamm
Ulrika Warpman-Berglund
Julian Walfridsson
Sören Lehmann
Dan Grandér
Thomas Lundbäck
Per Kogner
Jan-Inge Henter
Thomas Helleday
Torsten Schaller
Nature Medicine, 2017, 23 : 256 - 263
[22] Cell-to-Cell Spreading of HIV-1 in Myeloid Target Cells Escapes SAMHD1 Restriction
Xie, Maorong
Leroy, Heloise
Mascarau, Remi
Woottum, Marie
Dupont, Maeva
Ciccone, Camille
Schmitt, Alain
Raynaud-Messina, Brigitte
Verollet, Christel
Bouchet, Jerome
Bracq, Lucie
Benichou, Serge
MBIO, 2019, 10 (06):
[23] Cytarabine Dose for Acute Myeloid Leukemia
Lowenberg, Bob
Pabst, Thomas
Vellenga, Edo
van Putten, Wim
Schouten, Harry C.
Graux, Carlos
Ferrant, Augustin
Sonneveld, Pieter
Biemond, Bart J.
Gratwohl, Alois
de Greef, Georgine E.
Verdonck, Leo F.
Schaafsma, Martijn R.
Gregor, Michael
Theobald, Matthias
Schanz, Urs
Maertens, Johan
Ossenkoppele, Gert J.
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1027 - 1036
[24] Cytarabine in relapsed acute myeloid leukemia
Hardesty, Brandon M.
Cripe, Larry D.
LEUKEMIA RESEARCH, 2012, 36 (04) : 387 - 388
[25] Cytarabine Dose for Acute Myeloid Leukemia
Mori, Jinichi
Tsubokura, Masaharu
Kami, Masahiro
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2166 - 2167
[26] Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens
Rassidakis, George Z.
Herold, Nikolas
Myrberg, Ida Hed
Tsesmetzis, Nikolaos
Rudd, Sean G.
Henter, Jan-Inge
Schaller, Torsten
Ng, Siok-Bian
Chng, Wee Joo
Yan, Benedict
Ng, Chin Hin
Ravandi, Farhad
Andreeff, Michael
Kantarjian, Hagop M.
Medeiros, L. Jeffrey
Xagoraris, Ioanna
Khoury, Joseph D.
BLOOD CANCER JOURNAL, 2018, 8
[27] Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens
George Z. Rassidakis
Nikolas Herold
Ida Hed Myrberg
Nikolaos Tsesmetzis
Sean G. Rudd
Jan-Inge Henter
Torsten Schaller
Siok-Bian Ng
Wee Joo Chng
Benedict Yan
Chin Hin Ng
Farhad Ravandi
Michael Andreeff
Hagop M. Kantarjian
L. Jeffrey Medeiros
Ioanna Xagoraris
Joseph D. Khoury
Blood Cancer Journal, 8
[28] The Proteostasis Network Is a Therapeutic Target in Acute Myeloid Leukemia
Lam, Kentson
Kim, Yoon Joon
Ong, Carlo M.
Liu, Andrea Z.
Zhou, Fanny Jiahua Jiahua
Chua, Bernadette A.
Vicenzi, Silvia
Ford, Pierce W.
Zhou, Jie-Hua
Bennett, Eric
Crews, Leslie A.
Ball, Edward D.
Signer, Robert
BLOOD, 2024, 144 : 2767 - 2768
[29] mTOR, a new therapeutic target in acute myeloid leukemia
Récher, C
Dos Santos, C
Demur, C
Payrastre, B
CELL CYCLE, 2005, 4 (11) : 1540 - 1549
[30] Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia
Chen, Fangli
Liu, Ligen
Chen, Huijie
Wu, Yicheng
Wang, Yuanqin
Fu, Zhen
Zhang, Tinghua
Jiang, Xuewei
Lu, Yingting
Zhao, Limin
Li, Jutang
Yang, Li
BLOOD, 2024, 144 : 5842 - 5842

← 1 2 3 4 5 →